Employees
Göran Nordström
Founding Partner / Chief Executive Officer
Employed at Rhenman & Partners since: 2008
Over 30 years of experience in leading financial positions.
Education: LL.B., Master of Laws, University of Stockholm, Financial Analyst, IFL.
Henrik Rhenman
Founding Partner / Chief Investment Officer
Employed at Rhenman & Partners since: 2008
Over 25 years of experience in portfolio management.
Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.
Susanna Urdmark
Co-Head/Senior Portfolio Manager
Employed at Rhenman & Partners since: 2017.
25 years of experience from investing in the healthcare sector.
Education: M.Sc., Stockholm School of Economics. M.A. in Medical Sciences, Boston University School of Medicine.
Kaspar Hållsten
Portfolio Manager
Employed at Rhenman & Partners since: 2017.
Education: Business Administration, Finance, B.Sc., Stockholm Business School.
Staffan Knafve
Senior Advisor
Affiliated to Rhenman & Partners since: 2012.
Over 30 years of experience in the stock market.
Education: LL.B., Master of Laws, University of Stockholm.
Hugo Schmidt
Analyst
Employed at Rhenman & Partners since: 2020.
Education: B.Sc. Business & Economics, Stockholm School of Economics.
Erica Nordström Löf
Relationship Manager
Employed at Rhenman & Partners since: 2022.
10 years of experience in wealth management. Education: M.Sc. in Business Administration, Finance, Linköping University
Karin Hjertén
Communications Manager
Employed at Rhenman & Partners since: 2021.
15 years of experience form marketing and communications roles within the financial sector. Education: M.Sc. in Business and Economics, Karlstad University.
Camilla Hermansson
Assistant, Client Relations Sweden
Employed at Rhenman & Partners since: 2011.
Board of Directors
Professor Hans Wigzell
Chairman of the Board
Professor emeritus of Immunology, Karolinska Institutet. Former president of Karolinska Institutet, head of the Infectious Disease Institute, the State Bacteriological Laboratory and chair of Karolinska Institutet’s Nobel Committee. Member of the Royal Academy of Sciences and the Royal Swedish Academy of Sciences IVA. Total number of active board assignments: 4.
Birgitta Stymne Göransson
Director
M.Sc. in Chemistry/Biotechnology, Royal Institute of Technology (KTH), and MBA Harvard Business School. Board member Elekta AB, Pandora A/S, BCB Medical Oy, Bure Equity AB and Chairman of the Boards of Industrifonden. Previously CEO of Memira Group, COO at Telefos, McKinsey Associate and Product manager at Gambro. Total number of active board assignments: 6
Håkan Åström
Director
Med.Dr.h.c. University of Gothenburg, Master of Science in Economics and Business Administration, Stockholm School of Economics. Chairman of the Board of 20 North Street (RP) AB. Previous Chairman of the Board of Swedish Orphan Biovitrum AB, Orexo AB, Affibody Medical AB, Egetis Therapeutics AB, FerrosanAS and FerrosanMedical AS. CEO of KabiPharmacia AB, Astra Pharmaceutical Ltd. Several other leading positions in the pharmaceutical industry. Total number of active board assignments: 2.
Henrik Rhenman
Director
Biochemist, Royal Institute of Technology and M.Sc., School of Business. Founder and Managing Director, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. Managing Director, Portfolio Manager, SG Cowen, Boston. Portfolio manager, SEB Pharmaceutical Fund. Head of Analysis, Hagströmer & Qviberg. Total number of active board assignments: 2.
Lars Wedenborn
Director
Degree of Master of Science in Business and Economics, Uppsala Universitet Chairman of the bord in AMF Tjänstepension, Nyvik Group Board member in Höganäs AB, IPCO AB, The Stockholm Chamber of Commerce (Vice Chairman), Rederi AB Gotland, tbd30 Previously CEO of FAM AB, CFO Alfred Berg and CFO Investor AB. Previously Board member at Nasdaq Group Inc, SKF, Grand Hôtel och FAM. Total number of active board assignments: 8st